Matches in SemOpenAlex for { <https://semopenalex.org/work/W2034347557> ?p ?o ?g. }
Showing items 1 to 68 of
68
with 100 items per page.
- W2034347557 endingPage "47" @default.
- W2034347557 startingPage "43" @default.
- W2034347557 abstract "Abstract Alzheimer's disease (AD) is a growing problem in an ageing population. Specific symptomatic treatments are now available for use in AD. The cholinesterase inhibitors (ChEIs) donepezil, galantamine and rivastigmine improve cholinergic function providing modest but clinically relevant improvements in cognition, activities of daily living, behaviour and consequently a reduction in caregiver burden. AD is a degenerative disorder and symptomatic treatments do not stop the underlying disease process. Nevertheless, despite an overall decline in cognitive scores over time, patients still maintain an advantage over untreated patients, demonstrated for donepezil in placebo-controlled studies of 1 year's duration. Continued treatment may help to delay the need for 24-hour care. The ChEIs have broadly similar efficacy despite some differences in modes of action and side-effects. Memantine is an NMDA receptor antagonists licensed for the treatment of moderate to severe AD, although, as with the ChEIs, there are studies demonstrating benefits in the whole spectrum of the disease. Memantine is well tolerated and although the original pivotal study in moderately severe AD showed benefits in terms of slowing of decline, improvements have been seen when used in conjunction with donepezil and in mild-to-moderate AD studies. The additional benefit demonstrated by addressing both the glutamatergic and cholinergic dysfunction may herald more combined approaches to treating this complex disease. Other avenues, such as antioxidants, oestrogens and anti-inflammatory drugs, have not shown any convincing benefits. The use of statins has shown some early positive results and a definitive trial is in progress." @default.
- W2034347557 created "2016-06-24" @default.
- W2034347557 creator A5067119495 @default.
- W2034347557 date "2005-01-01" @default.
- W2034347557 modified "2023-10-18" @default.
- W2034347557 title "Pharmacotherapy of Alzheimer's disease" @default.
- W2034347557 cites W1975865267 @default.
- W2034347557 cites W1997886955 @default.
- W2034347557 cites W2031709382 @default.
- W2034347557 cites W2037099926 @default.
- W2034347557 cites W2047095305 @default.
- W2034347557 cites W2057679568 @default.
- W2034347557 cites W2099833638 @default.
- W2034347557 cites W2113262032 @default.
- W2034347557 cites W2122692162 @default.
- W2034347557 cites W2131266318 @default.
- W2034347557 cites W2132806643 @default.
- W2034347557 cites W2151603390 @default.
- W2034347557 cites W2152681246 @default.
- W2034347557 cites W2158660192 @default.
- W2034347557 cites W2161717665 @default.
- W2034347557 doi "https://doi.org/10.1383/psyt.4.1.43.58305" @default.
- W2034347557 hasPublicationYear "2005" @default.
- W2034347557 type Work @default.
- W2034347557 sameAs 2034347557 @default.
- W2034347557 citedByCount "4" @default.
- W2034347557 countsByYear W20343475572014 @default.
- W2034347557 countsByYear W20343475572019 @default.
- W2034347557 countsByYear W20343475572022 @default.
- W2034347557 crossrefType "journal-article" @default.
- W2034347557 hasAuthorship W2034347557A5067119495 @default.
- W2034347557 hasConcept C118552586 @default.
- W2034347557 hasConcept C126322002 @default.
- W2034347557 hasConcept C15744967 @default.
- W2034347557 hasConcept C169760540 @default.
- W2034347557 hasConcept C2779134260 @default.
- W2034347557 hasConcept C500440147 @default.
- W2034347557 hasConcept C502032728 @default.
- W2034347557 hasConcept C71924100 @default.
- W2034347557 hasConceptScore W2034347557C118552586 @default.
- W2034347557 hasConceptScore W2034347557C126322002 @default.
- W2034347557 hasConceptScore W2034347557C15744967 @default.
- W2034347557 hasConceptScore W2034347557C169760540 @default.
- W2034347557 hasConceptScore W2034347557C2779134260 @default.
- W2034347557 hasConceptScore W2034347557C500440147 @default.
- W2034347557 hasConceptScore W2034347557C502032728 @default.
- W2034347557 hasConceptScore W2034347557C71924100 @default.
- W2034347557 hasIssue "1" @default.
- W2034347557 hasLocation W20343475571 @default.
- W2034347557 hasOpenAccess W2034347557 @default.
- W2034347557 hasPrimaryLocation W20343475571 @default.
- W2034347557 hasRelatedWork W2072098281 @default.
- W2034347557 hasRelatedWork W2082482010 @default.
- W2034347557 hasRelatedWork W2106304681 @default.
- W2034347557 hasRelatedWork W2338128126 @default.
- W2034347557 hasRelatedWork W2393857598 @default.
- W2034347557 hasRelatedWork W2768303128 @default.
- W2034347557 hasRelatedWork W2993054172 @default.
- W2034347557 hasRelatedWork W2997708235 @default.
- W2034347557 hasRelatedWork W4237179850 @default.
- W2034347557 hasRelatedWork W4306247679 @default.
- W2034347557 hasVolume "4" @default.
- W2034347557 isParatext "false" @default.
- W2034347557 isRetracted "false" @default.
- W2034347557 magId "2034347557" @default.
- W2034347557 workType "article" @default.